(Q39547723)

13 September 2017

Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin (English)

1 reference

13 September 2017

0 references

1 reference

Jun-Shik Choi

1

1 reference

PubMed ID

21544726

13 September 2017

Yong-Ji Piao

series ordinal

2

1 reference

PubMed ID

21544726

13 September 2017

Keon Wook Kang

series ordinal

3

1 reference

13 September 2017

1 April 2011

1 reference

Archives of Pharmacal Research

13 September 2017

1 reference

13 September 2017

34

1 reference

13 September 2017

4

1 reference

13 September 2017

607-613

1 reference

https://scigraph.springernature.com/pub.10.1007/s12272-011-0411-x

13 September 2017

0 references

cites work

Inhibitors of multidrug resistance to antitumor agents (MDR).

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Interaction of the breast cancer resistance protein with plant polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Pharmacokinetics of combined doxorubicin and paclitaxel in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Clinical pharmacokinetics of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0411-X

10.1007/S12272-011-0411-X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

21544726